Wegovy (semaglutide) Wegovy is a GLP-1 agonist medication that is approved to: Aid in weight loss for adults and children over 12 years old who have obesity, or in adults who have overweight and have a weight-related health condition (such as high blood pressure, type 2 diabetes , or high cholesterol) Reduce the risk of major cardiovascular events, such as heart attack or stroke, in adults who have cardiovascular disease and have obesity or overweight Wegovy comes in a single-use pen that you inject once per week, either with or without food
In just 2 short months, I am down 25 pounds and feel better than ever. outcomes firstALWAYS Explore the inspiring journeys of our patients, who have transformed their health and well-being through Nuforms personalized care
The takeaway: Better kidney health keeps fatigue and swelling at bay and lowers the chance youll face future restrictions on diet or medication
Couzin-Frankel 22 Sept 2023 Barany, Barany)
"I should be one of the enthusiastic ones, but in reality, I'm one of the skeptics, or cautious at least," says Riccardo De Giorgi, psychiatrist and clinical researcher who studies mental health and GLP-1s at the University of Oxford
Side effects such as nausea, diarrhea, vomiting and constipation that are common early on may also drive people away